 These recommendations are supported by
two recent systematic reviews34,35 (Table XXIV). The
2018 Cochrane review included 33 studies involving 7296
patients with SVT of the legs.34 Treatments evaluated
included fondaparinux, rivaroxaban, LMWH, unfractionated heparin, NSAIDS, compression stockings, and
topical, intramuscular, or intravenous treatment as well
as